¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"toxic agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • spermicidal agent
    »ìÁ¤ÀÚÁ¦
  • sclerosing agent
    °æÈ­Á¦
  • single-agent chemotherapy
    ´ÜÀÏÁ¦Á¦Ç×¾ÏÈ­Çпä¹ý
  • volatile agent
    Èֹ߼º¾à
  • volatile inhalation agent
    Èֹ߼ºÈíÀÔ¸¶ÃëÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bulking agent
    ÀåÈ®À强¾à¹°
  • carcinogenic agent
    ¹ß¾Ï¹°Áú
  • carcinostatic agent
    Á¦¾ÏÁ¦
  • cardioactive agent
    ½ÉÀåÀÛ¿ë¾à
  • cardiotonic agent
    °­½ÉÁ¦
  • causative agent
    º´¿øÃ¼, ¿øÀι°Áú
  • chemotherapeutic agent
    È­Çпä¹ýÁ¦
  • cholinergic agent
    Äݸ°¼º¾à¹°
  • cholinergic blocking agent
    Äݸ°Â÷´ÜÁ¦
  • compounding agent
    ¹èÇÕÁ¦, Á¶ÇÕÁ¦
  • contrast agent
    Á¶¿µÁ¦
  • cryoprotective agent
    µ¿ÇعæÁöÁ¦, ³Ãµ¿»óÇØ¹æÁöÁ¦
  • curariform agent
    Äí¶ó·¹À¯»çÁ¦
  • curing agent
    °æÈ­Á¦
  • cytotoxic agent
    ¼¼Æ÷µ¶¼ºÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hydrotropic agent =emulsifying a.
    À¯È­Á¦(êáûùð¥).
  • hypoglycemic agent
    Ç÷´ç°­ÇϾà.
  • hypotensive agent
    °­¾ÐÁ¦(˽äâð¥).
  • immunosuppresive agent
    ¸é¿ª¾ïÁ¦Á¦
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ.
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ.
  • induction agent
    À¯µµ¹°Áú
  • infective agent
    °¨¿°ÀÎÀÚ.
  • inotropic agent
    ¼öÃàÃËÁøÁ¦(¡­ð¥).
  • physical agent
    ¹°¸®Àû ÀÎÀÚ(Úª×âîÜ ì×í­)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦.
  • protective agent
    º¸È£¾à, ÇÇÆ÷¾à(̰̰Ëâ).
  • psychedelic agent
    ȯ°¢Á¦.
  • psychotropic agent =psychotrotropic
    Á¤½ÅÀÛ¿ë¾à(¡­íÂéÄå·).
  • radioopaque agent
    ¹æ»ç¼± ºñÅõ°ú¼º Á¦Àç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • toxic injury, cellular
    µ¶¼º »óÇØ(¼Õ»ó), ¼¼Æ÷¼º
  • toxic lesion
    Áßµ¶¼ºº´º¯(ñéÔ¸àõܻܨ)
  • toxic leukocytosis
    Áßµ¶¼º¹éÇ÷±¸Áõ°¡Áõ(¡­ÛÜúìϹñòÊ¥ñø)
  • toxic megacolon
    Áßµ¶¼º°Å´ë°áÀåÁõ(¡­ËÝÓÞÌ¿íóñø).
  • toxic megacolon
    µ¶¼º°Å´ë°áÀåÁõ(¡­ËÝÓÞÌ¿íóñø)
  • toxic myelopathy
  • toxic myocarditis
    Áßµ¶¼º½É±Ù¿°(¡­ãýÐÉæú)
  • toxic necrosis
    Áßµ¶¼º±«»ç(¡­ÎÕÞÝ)
  • toxic nephropathy
    Áßµ¶¼º ½Åº´Áõ
  • toxic nephrosclerosis
    Áßµ¶¼º½Å°æÈ­Áõ(¡­ãìÌãûùñø)
  • toxic nephrosis
    Áßµ¶¼º½ÅÁõ(¡­ãìñø)
  • toxic neuritis
    Áßµ¶¼º½Å°æ¿°(¡­ãêÌèæú).
  • toxic neuritis
    Áßµ¶¼º½Å°æ¿°(¡­ãêÌèæú)
  • toxic psychosis
    µ¶¼ºÁ¤½ÅÁõ(~ïñãêñø).
  • toxic reaction
    µ¶¹ÝÀÀ(Ô¸Úãëë), Áßµ¶¹ÝÀÀ(ñéÔ¸Úãëë).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HRLA human reovirus-like agent
IAA imidazoleacetic acid; indoleacetic acid; infectious agent, arthritis; insulin autoantibody; Internat...
LAN local area network; long-acting neuroleptic [agent]
MAT manual arts therapist; master of arts in technology; mean absorption time; medical assistance team (...
MINIA monkey intranuclear inclusion agent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
TSST-1 Toxic Shock Syndrome Toxin-1
TSCA Toxic Substance Control Act
TA Toxic adenoma
TSST Toxic shock syndrome toxin
TSLS Toxic shock-like syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • emulsifying agent
    ¿¡¸ÖÁ¯È­Á¦, À¯È­Á¦
  • etiologic agent
    º´ÀÎü
  • fixing agent
    °íÁ¤Á¦, Á¤ÂøÁ¦
  • flavoring agent
    Çâ¹Ì·á, ¹æÇâ ¾à
  • human parvovirus-like agent
    »ç¶÷ ÆÄº¸ ¹ÙÀÌ·¯½º À¯»çü
  • immunosupressive agent
    ¸é¿ª ¾ïÁ¦Á¦
  • immuuppressive agent
    ¸é¿ª ¾ïÁ¦Á¦
  • infectious agent
    °¨¿° ÀÎÀÚ
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • intercalating agent
    Áß°ÝÁ¦
  • miscellaneous agent
    ±âŸ Á¦Á¦
  • neuromuscular blocking agent
    ½Å°æ±Ù Â÷´ÜÁ¦, ½Å°æ±Ù Â÷´Ü ¾à
  • nondepolarizing agent
    ºñÅ»ºÐ±ØÁ¦, ºñÅ»ºÐ±Ø¼ºÁ¦
  • oral hypoglycemic agent
    °æ±¸ ´ç´¢º´ ¾àÁ¦
  • oxidizing agent
    »êÈ­Á¦
    »êÈ­µÇ´Â ¹°ÁúÀÇ ¿øÀÚ¿¡ ¾ç ÀüÇϸ¦ Áõ°¡½ÃŰ°Å³ª À½ ÀüÇϸ¦ °¨¼Ò½ÃŰ´Â ¾àÁ¦.
  • paramagnetic agent
    »óÀÚ¼º Á¦Àç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
bacteriostatic agent Any agent that inhibits or retards bacterial growth.
Synonym: bacteriostatic agent.
(05 Mar 2000)
beta-adrenergic blocking agent A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable.
Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker.
(05 Mar 2000)
beta-adrenergic receptor blocking agent A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable.
Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker.
(05 Mar 2000)
biological agent <microbiology> A disease-causing microorganism or virus, or other toxic biological matter, which is used as a weapon during war.
(21 Mar 1998)
Bittner agent <virology> Earlier name, now superseded, for the mouse mammary tumour virus.
(18 Nov 1997)
blister agent <chemistry, pharmacology> Refers to a chemical or agent that causes blisters.
(09 Oct 1997)
blocking agent A class of drugs that inhibit (block) a biologic activity or process, such as axonal conduction or transmission, or ions across a cell membrane; frequently called "blockers."
(05 Mar 2000)
bronchoconstrictor agent Agents causing the narrowing of the lumen of a bronchus or bronchiole.
(12 Dec 1998)
cardiotonic agent Agents that have a tonic effect on the heart or increase cardiac output. They may be glycosidic steroids related to digitalis products, sympathomimetic, or other drugs and are used after myocardial infarcts, cardiac surgery, in shock, or in congestive heart failure.
(12 Dec 1998)
cariogenic agent Substances conducive to the production of dental caries.
(12 Dec 1998)
cariostatic agent Substances that inhibit or arrest dental caries formation.
(12 Dec 1998)
ganglionic blocking agent An agent that impairs the passage of impulses in autonomic ganglia.
(05 Mar 2000)
reducing agent A molecule that donates an electron in an oxidation-reduction reaction.
(09 Oct 1997)
reovirus-like agent <virology> Genus of the Reoviridae having a double layered capsid and 11 double stranded RNA molecules in the genome. They have a wheel like appearance in the electron microscope and cause acute diarrhoeal disease in their mammalian and avian hosts.
Probably the most important cause of severe dehydrating diarrhoea in children under three years of age worldwide.
Symptoms include nausea, vomiting, low-grade fever and diarrhoea. Aggressive fluid replacement is generally required.
(27 Sep 1997)
chemotherapeutic agent Chemotherapeutic agents are those medications that are used to treat various forms of cancer. These medications are given in a particular regimen over a period of weeks. most chemotherapeutic medications have the ability to directly kill cancer cells. For this same reason, these medications can suppress the bone marrow to some degree, lowering white blood cell counts. This results in a condition known as immunosuppression and can place the patient at an increased risk of infection.
Examples include busulphan, cisplatin, cyclophosphamide, methotrexate, daunorubicin, doxorubicin, melphalan, vincristine, vinblastine and chlorambucil.
See: immunosuppressive agents.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á